GlassScriptPhysician profile
Amber R Lange
NPI 1982195855
$3,954.76
in general payments reported to CMS, 2019-2025
23 companies · $577 in 2025
The $577 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $541 · 2021: $374 · 2022: $631 · 2023: $432 · 2024: $445 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Entertainment: $33.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.56 |
| Entertainment | $33.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,069.88 | 2019-2025 | Tryptyr, Precision7, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $452.06 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $404.38 | 2022-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $309.48 | 2019-2023 | Cequa |
| Johnson & Johnson Vision Care, INC. | $267.75 | 2022-2024 | |
| Abbvie INC. | $259.07 | 2022-2025 | |
| Allergan, INC. | $188.96 | 2020-2022 | |
| Lombart Brothers, INC. | $143.56 | 2019 | |
| Shire North American Group INC | $132.55 | 2019 | |
| Coopervision INC. | $130.68 | 2019-2025 | Misight Contact Lens |
| Sight Sciences, INC. | $94.49 | 2025 | Tearcare System |
| Biotissue Holdings INC. | $85.94 | 2021-2024 | |
| Tarsus Pharmaceuticals, INC. | $68.15 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $66.90 | 2024-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $47.85 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $46.89 | 2024-2025 | Iheezo, Triesence |
| Kala Pharmaceuticals, INC. | $41.17 | 2021-2022 | |
| Optos, INC. | $33.36 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $31.47 | 2022 | |
| Glaukos Corporation | $28.38 | 2023 | |
| New World Medical,INC. | $18.64 | 2021 | |
| Lkc Technologies, INC. | $17.93 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $15.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Lange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.